725 related articles for article (PubMed ID: 27768886)
21. Different Life Cycle Stages of
Yap XZ; Lundie RJ; Feng G; Pooley J; Beeson JG; O'Keeffe M
Front Immunol; 2019; 10():32. PubMed ID: 30766530
[TBL] [Abstract][Full Text] [Related]
22. Development of a malaria vaccine.
Kwiatkowski D; Marsh K
Lancet; 1997 Dec; 350(9092):1696-701. PubMed ID: 9400530
[TBL] [Abstract][Full Text] [Related]
23. Liver stage antigen and malaria.
Luft FC
J Mol Med (Berl); 2004 Sep; 82(9):555-7. PubMed ID: 15300330
[No Abstract] [Full Text] [Related]
24. Aotus nancymaae as a potential model for the testing of anti-sporozoite and liver stage vaccines against Plasmodium falciparum.
Collins WE; Sullivan JS; Williams A; Nace D; Williams T; Galland GG; Barnwell JW
Am J Trop Med Hyg; 2006 Mar; 74(3):422-4. PubMed ID: 16525100
[TBL] [Abstract][Full Text] [Related]
25. Malaria vaccine development: lessons from the field.
Todryk S; Bejon P
Eur J Immunol; 2009 Aug; 39(8):2007-10. PubMed ID: 19672893
[TBL] [Abstract][Full Text] [Related]
26. Malaria vaccine: a bright prospect for elimination of malaria.
Bairwa M; Rajput M; Khanna P; Rohilla R; Verma R; Chawla S
Hum Vaccin Immunother; 2012 Jun; 8(6):819-22. PubMed ID: 22739688
[TBL] [Abstract][Full Text] [Related]
27. Pre-erythrocytic malaria vaccines to prevent Plasmodium falciparum malaria.
Ballou WR; Kester KE; Heppner DG
Chem Immunol; 2002; 80():253-61. PubMed ID: 12058643
[No Abstract] [Full Text] [Related]
28. A natural immunization process prevents malaria.
Todryk SM
Trends Parasitol; 2010 May; 26(5):219-21. PubMed ID: 20189878
[No Abstract] [Full Text] [Related]
29. Developmental biology of sporozoite-host interactions in Plasmodium falciparum malaria: implications for vaccine design.
Garcia JE; Puentes A; Patarroyo ME
Clin Microbiol Rev; 2006 Oct; 19(4):686-707. PubMed ID: 17041140
[TBL] [Abstract][Full Text] [Related]
30. Overview: immunology of malaria and progress in malaria vaccine development.
Tharavanij S
Southeast Asian J Trop Med Public Health; 1992 Sep; 23 Suppl 4():71-87. PubMed ID: 1364871
[No Abstract] [Full Text] [Related]
31. The malaria vaccine--status quo 2013.
Heppner DG
Travel Med Infect Dis; 2013; 11(1):2-7. PubMed ID: 23454205
[TBL] [Abstract][Full Text] [Related]
32. Protective immunity against malaria by 'natural immunization': a question of dose, parasite diversity, or both?
Borrmann S; Matuschewski K
Curr Opin Immunol; 2011 Aug; 23(4):500-8. PubMed ID: 21719266
[TBL] [Abstract][Full Text] [Related]
33. Functional genomics, new tools in malaria research.
Di Girolamo F; Raggi C; Bultrini E; Lanfrancotti A; Silvestrini F; Sargiacomo M; Birago C; Pizzi E; Alano P; Ponzi M
Ann Ist Super Sanita; 2005; 41(4):469-77. PubMed ID: 16569915
[TBL] [Abstract][Full Text] [Related]
34. Vaccination using normal live sporozoites under drug treatment.
Rénia L; Grüner AC; Mauduit M; Snounou G
Methods Mol Biol; 2013; 923():567-76. PubMed ID: 22990805
[TBL] [Abstract][Full Text] [Related]
35. Strategies & recent development of transmission-blocking vaccines against
Chaturvedi N; Bharti PK; Tiwari A; Singh N
Indian J Med Res; 2016 Jun; 143(6):696-711. PubMed ID: 27748294
[TBL] [Abstract][Full Text] [Related]
36. Challenges of drug-resistant malaria.
Sinha S; Medhi B; Sehgal R
Parasite; 2014; 21():61. PubMed ID: 25402734
[TBL] [Abstract][Full Text] [Related]
37. Immunogenicity of a chimeric Plasmodium falciparum merozoite surface protein vaccine in Aotus monkeys.
Burns JM; Miura K; Sullivan J; Long CA; Barnwell JW
Malar J; 2016 Mar; 15():159. PubMed ID: 26975721
[TBL] [Abstract][Full Text] [Related]
38. Harnessing immune responses against Plasmodium for rational vaccine design.
Douradinha B; Doolan DL
Trends Parasitol; 2011 Jun; 27(6):274-83. PubMed ID: 21531627
[TBL] [Abstract][Full Text] [Related]
39. Circumsporozoite protein as a potential target for antimalarials.
Fernández-Arias C; Mashoof S; Huang J; Tsuji M
Expert Rev Anti Infect Ther; 2015 Aug; 13(8):923-6. PubMed ID: 26081442
[TBL] [Abstract][Full Text] [Related]
40. Surface antigens of Plasmodium falciparum gametocytes--a new class of transmission-blocking vaccine targets?
Sutherland CJ
Mol Biochem Parasitol; 2009 Aug; 166(2):93-8. PubMed ID: 19450726
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
